Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles. Breakdown of immune privilege in hair follicles leads to ...

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

Alopecia refers to hair loss and can affect the scalp, eyebrows, eyelashes, and other areas of the body. There are different types of alopecia including an | Immunology ...

Comorbid chronic inflammatory diseases influence the prognosis of alopecia areata, according to study findings.

The goal is to find a cure for alopecia areata, an autoimmune disease that causes hair loss in distinct round patches.

In a new JAMA Dermatology study, scientists at King's College London found that changes in two parts of the genome work ...

Atopy from food allergies to environmental factors can increase hair loss prevalence among children and adults, according to ...

Everyone’s alopecia areata is different. Even though everyone who has it experiences hair loss, it may have many variations, including where, when, and how often you lose your hair. Alopecia ...

The company said it is evaluating its strategic options regarding ADX-097 as it shifts efforts over to pushing bempikibart.

If you haven’t found the right treatment for your alopecia areata yet, it may be right around the corner. There’s no cure for alopecia areata, but even with this condition, your hair follicles ...

Six-year-old Grace has a condition that means her hair breaks as it grows, leaving her with only patches of hair on her head. Her mum Toni Smith, 35, has started a GoFundMe page to raise money for a ...